NFKB1 and atrial fibrillation: Blockade of TRPV4 prevents AF and reduces fibrosis in aseptic pericardial mice by inhibiting the ERK/NF-κB/NLRP3 pathway (Yang et al., 2022; Zhang H et al., 2022).